GSK to Pay $90 Million as Settlement for Misrepresenting Avandia Claims

by Kathy Jones on  November 16, 2012 at 6:09 PM Drug News
RSS Email Print This Page Comment
GlaxoSmithKline has agreed to pay more than $90 million to 38 states as part of settling the claims that the company deliberately misrepresented the health risks associated with diabetes drug Avandia.
 GSK to Pay $90 Million as Settlement for Misrepresenting Avandia Claims
GSK to Pay $90 Million as Settlement for Misrepresenting Avandia Claims

A Senate Committee report had earlier found that Avandia increased the risk of cardiovascular disease in diabetic patients and GSK had known about the health risks but had decided not to reveal it.

The company had been accused of indulging in illegal means to promote the drug and has so far paid more than $3 billion in order to settle federal charges and consumer lawsuits.

Source: Medindia

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive